Filing Details
- Accession Number:
- 0001104659-23-006677
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-26 06:03:37
- Reporting Period:
- 2023-01-25
- Accepted Time:
- 2023-01-26 06:03:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 894158 | Theriva Biologics Inc. | TOVX | Pharmaceutical Preparations (2834) | 133808303 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1263501 | A Steven Shallcross | C/O Theriva Biologics, Inc.,, 9605, Medical Center Drive, Suite 270 Rockville MD 20850 | Ceo And Cfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-25 | 25,000 | $0.87 | 160,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.860 through $0.875, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
